The boronated aromatic amino acids were shown to be potent hypolipidemic agents in mice lowering both serum cholesterol and triglycerides aer 16 days. Selective compounds were as effective as the clinical standards. Furthermore, the compounds were effective anti-inflammatory agents reducing local and central pain as well as suppressing LPS induced endotoxic shock in mice. These agents inhibited lysosomal and proteolytic enzymes of the liver and macrophages as a part of their mechanism of action.
INTRODUCTION
L-Phenylalanine, tyrosine, proline, histidine and tryptophan boronated derivatives as well as their metal complexes have recently been shown to be potent antineoplastic or cytotoxic agents [1] [2] [3] [4] [5] [6] . Previously with the boron analogues of o-amino acids, i.e amine-carboxyboranes, heterocyclic amine boranes and 2'-deoxynucleoside boranes other biological activities, e.g. hypolipidemic [7] [8] [9] [10] [11] [12] [13] , antiarthritic, antiinflammatory, antiosteoporoeous [14] [15] [16] [17] [18] [19] have been demonstrated in rodents. The present investigation involved the examination of boronated aromatic amino acids as potent hypolipidemic or anti-inflammatory agents in mice at 8 mg/kg, I.P.
MATERIAL AND METHODS

Source of Compounds
All of the boronated aromatic amino acids or their metal complexes were synthesized and published previously: 2-[(N-methylmethanamine)methyl-carbonyl]amino-3-phenyl-methyl propanoate 3 [6] 6 [3] , sodium -2-(N,N-dimethylmethanamine)dihydroboron-carbonyl]amino-3-phenyl-propanoate 7 [5] , tetrakis-{2-[N,Ndimethylmethanamine)dihydroboron-carbonyl]am ino-3-phenyl-propyl carboxylate}-bis-{2-[N,N-dimethylmethanamine)dihydroboron-carbonyl]amino-3-phenyl-propanoate}dicopper(II) 8 [5] , (ammonia) [3] , [3] , N-acetyl-4-boronphenylalanylphenylalanine methyl ester 15 [2] , N-acetyl-4-boronphenylalanyltyrosine methyl ester 16 [2] , N-[(trimethylamineboryl)-carbonyl]-L-histidinemethyl ester 17 [4] , N-[(trimethylamineboryl)-carbonyl]Ltryphophan methyl ester 18 [4] . 
Merrill C. were maintained in Dulbecco's modified medium (DMEM) + 15% fetal calf serum + P/S were homogenized.
All of the methods for the enzyme studies have been described previously [16] . Acid 16 . Again this magnitude of reduction of triglycerides was highly significant compared to the standard drug effects on this lipid component. Their anti-inflammatory effects of the boronated aromatic amino acids was not as significant as those observed for the at-amino boranes [16] . The sodium-2-(N,N-dimethylmethanamine)dihydroboron carbonyl)amino-3-phenylpropanoate 7 11 was the only compound that was as active as morphine in reducing central pain although compound 13 was significantly effective. The phenylalanine derivatives did not demonstrate any ability to block central pain. The boronated aromatic acids did protect the mouse from LPS induced shock and many of the tested derivatives were more potent than the standards dexamethasone and pentoxifylline at their therapeutic doses. Those compounds without a boron atom, compounds 1 and 2 offered no protection against LPS induced shock. Previously amine-carboxyboranes were shown to inhibit proteolytic and lysosomal hydrolytic enzyme activities [16] . The present study would suggest that similar mechanisms of action are caused by the boronated aromatic amino acids for their anti-inflammatory activity. The aminecarboxyboranes also suppressed prostaglandin synthetase and cytokine, e.g. II-1 and TNF release as well as the migration of white cells to the inflammation site [16] . Whereas further investigation of this group of compounds is required, they may offer some therapeutic use in the future because of the low dose required for their in vivo activity as hypolipidemic and anti-inflammatory agents.
